132 related articles for article (PubMed ID: 38519911)
21. CT characteristics predict the response to everolimus or sirolimus of renal angiomyolipomas in patients with tuberous sclerosis complex.
Wang W; Guo H; Shi B; Sun H; Li H; Zhang Y; Cai Y
Int Urol Nephrol; 2019 Apr; 51(4):671-676. PubMed ID: 30756282
[TBL] [Abstract][Full Text] [Related]
22. [Rapamycin in the treatment of renal diseases associated with tuberous sclerosis complex].
Dun S; Zou LP; Zhang MN; Wang YY; He W; Chen HM; Hu LY; Chen XQ; Lu Q; Pang LY; Liu LY; Tang LN; Wang B
Zhonghua Er Ke Za Zhi; 2019 Nov; 57(11):852-856. PubMed ID: 31665839
[No Abstract] [Full Text] [Related]
23. Natural history of patients with tuberous sclerosis complex related renal angiomyolipoma.
Song X; Liu Z; Cappell K; Gregory C; Said Q; Prestifilippo J; Charles H; Hulbert J; Bissler J
Curr Med Res Opin; 2017 Jul; 33(7):1277-1282. PubMed ID: 28358266
[TBL] [Abstract][Full Text] [Related]
24. Renal angiomyolipoma in Japanese tuberous sclerosis patients.
Kitano Y; Honna T; Nihei K; Miyauchi J; Matsuoka K; Kuroda T; Tanaka K; Morikawa N; Fuchimoto Y
J Pediatr Surg; 2004 Dec; 39(12):1784-6. PubMed ID: 15616929
[TBL] [Abstract][Full Text] [Related]
25. Outcomes of angioembolization and nephrectomy for renal angiomyolipoma associated with tuberous sclerosis complex: a real-world US national study.
Sun P; Liu J; Charles H; Hulbert J; Bissler J
Curr Med Res Opin; 2017 May; 33(5):821-827. PubMed ID: 28112545
[TBL] [Abstract][Full Text] [Related]
26. Treatment effect of mTOR-inhibition on tissue composition of renal angiomyolipomas in tuberous sclerosis complex (TSC).
Brakemeier S; Vogt L; Adams L; Zukunft B; Diederichs G; Hamm B; Budde K; Makowski MR
PLoS One; 2017; 12(12):e0189132. PubMed ID: 29232371
[TBL] [Abstract][Full Text] [Related]
27. How many surgically-treated angiomyolipomas are related to tuberous sclerosis complex? Insights from a retrospective multicenter study.
Champy CM; Campi R; Grande P; de la Taille A; Méjean A; Granger B; Bitker MO; Rouprêt M
Minerva Urol Nefrol; 2020 Apr; 72(2):200-206. PubMed ID: 31619031
[TBL] [Abstract][Full Text] [Related]
28. Tuberous sclerosis complex with end-stage renal failure.
Neumann HP; Brüggen V; Berger DP; Herbst E; Blum U; Morgenroth A; Schollmeyer P; Wetterauer U
Nephrol Dial Transplant; 1995; 10(3):349-53. PubMed ID: 7792029
[TBL] [Abstract][Full Text] [Related]
29. Spontaneous retroperitoneal hemorrhage due to massive rupture of renal angiomyolipoma treated with nephrectomy: an unusual onset of tuberous sclerosis complex.
Granata A; Basile A; Figuera M; Mignani R; Fiore CE
Clin Nephrol; 2009 Apr; 71(4):441-4. PubMed ID: 19356378
[TBL] [Abstract][Full Text] [Related]
30. Association between the growth rate of renal cysts/angiomyolipomas and age in the patients with tuberous sclerosis complex.
Tsai JD; Wei CC; Chen SM; Lue KH; Sheu JN
Int Urol Nephrol; 2014 Sep; 46(9):1685-90. PubMed ID: 24682862
[TBL] [Abstract][Full Text] [Related]
31. Bilateral Giant Renal Angiomyolipoma in a Patient with Tuberous Sclerosis Complex: A Case Report.
Afriansyah A; Yusuf AM; Nusaly H
Acta Med Indones; 2018 Jan; 50(1):61-65. PubMed ID: 29686177
[TBL] [Abstract][Full Text] [Related]
32. Wunderlich's Syndrome, or Spontaneous Retroperitoneal Hemorrhage, in a Patient with Tuberous Sclerosis and Bilateral Renal Angiomyolipoma.
Catarino Santos S; Duarte L; Valério F; Constantino J; Pereira J; Casimiro C
Am J Case Rep; 2017 Dec; 18():1309-1314. PubMed ID: 29217816
[TBL] [Abstract][Full Text] [Related]
33. [Angiomyolipoma of the kidneys as a rare cause of retroperitoneal hemorrhage. Two case reports with tuberous sclerosis Bourneville-Pringle].
May M; Seehafer M; Helke C; Stosiek P; Ehlers C; Hoschke B
Urologe A; 2003 May; 42(5):693-701. PubMed ID: 12750805
[TBL] [Abstract][Full Text] [Related]
34. Effects of everolimus on tuberous sclerosis complex-associated renal angiomyolipoma: A preliminary report.
Tsai JD; Wei CC; Yang SH; Fan HC; Hsu CC; Tung MC; Tsai ML; Sheu JN
Nephrology (Carlton); 2017 Dec; 22(12):1017-1022. PubMed ID: 27565896
[TBL] [Abstract][Full Text] [Related]
35. Mutational analysis of renal angiomyolipoma associated with tuberous sclerosis complex and the outcome of short-term everolimus therapy.
Ni J; Yan F; Qin W; Yu L; Zhang G; Liu F; Yang X; Yang B; Hao C; Wang T; Liu P; Yuan J; Wu G
Sci Rep; 2019 Oct; 9(1):14337. PubMed ID: 31586081
[TBL] [Abstract][Full Text] [Related]
36. Renal progression factors in young patients with tuberous sclerosis complex: a retrospective cohort study.
Janssens P; Van Hoeve K; De Waele L; De Rechter S; Claes KJ; Van de Perre E; Wissing KM; Bammens B; Jansen A; Mekahli D
Pediatr Nephrol; 2018 Nov; 33(11):2085-2093. PubMed ID: 29987458
[TBL] [Abstract][Full Text] [Related]
37. [Influence of pregnancy on renal angiomyolipoma].
Raft J; Lalot JM; Meistelman C; Longrois D
Gynecol Obstet Fertil; 2005 Nov; 33(11):898-906. PubMed ID: 16256402
[TBL] [Abstract][Full Text] [Related]
38. [Spontaneous rupture of renal angiomyolipoma with tuberous sclerosis during long-term follow-up: a case report].
Hamaguchi T; Kasahara K; Shuin T; Kataoka S
Hinyokika Kiyo; 2001 Sep; 47(9):645-8. PubMed ID: 11692603
[TBL] [Abstract][Full Text] [Related]
39. [HUGE RENAL ANGIOMYOLIPOMA (AML) IN TUBEROUS SCLEROSIS COMPLEX (TSC) WHICH IS CONTROLED BY EVEROLIMUS: A CASE REPORT].
Kanbara T; Sakaeda K; Kusaka N; Akebi N
Nihon Hinyokika Gakkai Zasshi; 2016; 107(1):54-58. PubMed ID: 28132993
[TBL] [Abstract][Full Text] [Related]
40. Rates of interventional procedures in patients with tuberous sclerosis complex-related renal angiomyolipoma.
Bissler J; Cappell K; Charles H; Song X; Liu Z; Prestifilippo J; Hulbert J
Curr Med Res Opin; 2015 Aug; 31(8):1501-7. PubMed ID: 26073843
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
